sri-project-1 | Anti-Infectives Development for National Institutes of Health | http://www.sri.com/work/projects/anti-infectives-development | description:SRI is conducting preclinical development of treatments for diseases such as tuberculosis, West Nile virus, hepatitis, and biodefense pathogens and toxins.
sri-project-2 | Needle-Free Transmucosal Drug Delivery System | http://www.sri.com/work/projects/needle-free-transmucosal-drug-delivery-system | description:SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.
sri-project-3 | Oral Formulation of DTPA to Counter Radiation Exposure | http://www.sri.com/work/projects/oral-formulation-dtpa-countermeasure-radiation-exposure | description:A new oral version of a known chelating agent can defend against mass radiation exposure in a terrorist attack.
sri-project-4 | SMARTT Projects: Treatments for Lung, Heart, Blood Diseases | http://www.sri.com/work/projects/smartt-projects-treatments-lung-heart-blood-diseases | description:Through a broad range of services for the National Institutes of Health, SRI is accelerating preclinical development of potential therapies for diseases that affect millions of people.
sri-project-5 | Toxicological Evaluation of Novel Ligands Program | http://www.sri.com/work/projects/toxicological-evaluation-novel-ligands-program | description:For the National Institute of Mental Health (NIMH), SRI performs preclinical safety and pharmacokinetics studies for brain imaging agents and drugs to treat mental illnesses.
